AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (April 1, 2003). doi:10.1152/ajpendo.00334.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/E163    most recent
00334.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimaraki, E. V.
Right arrow Articles by Barkan, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimaraki, E. V.
Right arrow Articles by Barkan, A. L.
Submitted on July 24, 2002
Accepted on March 23, 2003

Both pulsatile and nocturnal growth hormone secretion in men do not require periodic declines of somatostatin

Eleni V. Dimaraki1, Craig A. Jaffe2, Cyril Y. Bowers3, Peter Marbach4, and Ariel L. Barkan2*

1 Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan, Ann Arbor, Michigan, USA
2 Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan, Ann Arbor, Michigan, USA; Department of Veterans Affairs Medical Center, Ann Arbor, Michigan, USA
3 Department of Internal Medicine, Division of Endocrinology and Metabolism, Tulane University, New Orleans, Louisiana, USA
4 Novartis Pharma Ltd., Basle, Switzerland

* To whom correspondence should be addressed. E-mail: abarkan{at}umich.edu.

Using a continuous subcutaneous octreotide infusion to create constant supraphysiologic somatostatinergic tone, we have previously shown that GH pulse generation in women is independent of endogenous SRIH declines. Generalization of these results to men is problematic because GH regulation is sexually dimorphic. We have therefore studied nine healthy young men (age 26±6 years, BMI 23.3±1.2 kg/m2) during normal saline and octreotide infusion (8.4 µg/h) that provided stable plasma octreotide levels (764.5±11.6 pg/ml). GH was measured in blood samples obtained every 10 min for 24h. Octreotide suppressed 24-h mean GH by 52±13% (P=0.016), GH pulse amplitude by 47±12% (P=0.012), and trough GH by 39±12% (P=0.030), whereas GH pulse frequency and the diurnal rhythm of GH secretion remained essentially unchanged. The response of GH to GH-releasing hormone (GHRH) was suppressed by 38±15% (P=0.012), but the GH response to GH-releasing peptide-2 (GHRP-2) was unaffected. We conclude that like in women, in men, declines in hypothalamic SRIH secretion are not required for pulse generation and are not the cause of the nocturnal augmentation of GH secretion. We propose that GH pulses are primarily driven by GHRH whereas ghrelin might be responsible for the diurnal rhythm of GH.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
N. Baccam, G. Alonso, T. Costecalde, P. Fontanaud, F. Molino, I. C. A. F. Robinson, P. Mollard, and P.-F. Mery
Dual-Level Afferent Control of Growth Hormone-Releasing Hormone (GHRH) Neurons in GHRH-Green Fluorescent Protein Transgenic Mice
J. Neurosci., February 14, 2007; 27(7): 1631 - 1641.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.